心脑血管病防治
心腦血管病防治
심뇌혈관병방치
PREVENTION AND TREATMENT OF CARDIO-CEREBRAL-VASCULAR DISEASE
2015年
3期
180-182
,共3页
毕振云%李宝栋%刘景峰%齐策
畢振雲%李寶棟%劉景峰%齊策
필진운%리보동%류경봉%제책
甲泼尼龙%干扰素β%复发缓解型多发性硬化症
甲潑尼龍%榦擾素β%複髮緩解型多髮性硬化癥
갑발니룡%간우소β%복발완해형다발성경화증
Methylprednisolone%Interferon_beta(IFN_β)%Relapsing remitting multiple sclerosis
目的:观察急性期甲泼尼龙结合缓解期IFN_β治疗复发缓解型多发性硬化症(RRMS )的疗效。方法84例RRMS患者,随机分为观察组及对照组,每组各42例。观察组在急性期采用甲泼尼龙冲击疗法(MPPT )治疗,缓解期采用IFNβ_1b治疗;对照组在急性期采用MPPT治疗,缓解期注射0.9%氯化钠溶液。观察两组急性期疗效、不同时期的复发率、Kurtzke扩展残疾状况量表(EDSS )评分、磁共振(MRI )脑部病灶数量和体积及IFNβ_1b的不良反应。结果急性期MPPT治疗的84例患者,总有效率达97.62%。观察组两年总复发率(31.71%)低于对照组(71.43%),差异有统计学意义( P<0.01);观察组第2年复发率低于对照组,差异有统计学意义( P<0.01);且观察组第2年复发率低于第1年,差异有统计学意义( P<0.05)。第2年末-初始EDSS评分,观察组明显低于对照组,差异有统计学意义( P<0.01)。0~12个月和0~24个月,观察组MRI头部病灶数量和体积均明显低于对照组,差异有统计学意义( P<0.05)。结论对于RRMS患者,采用急性期MPPT结合缓解期IFN_β治疗可取得较好的疗效。
目的:觀察急性期甲潑尼龍結閤緩解期IFN_β治療複髮緩解型多髮性硬化癥(RRMS )的療效。方法84例RRMS患者,隨機分為觀察組及對照組,每組各42例。觀察組在急性期採用甲潑尼龍遲擊療法(MPPT )治療,緩解期採用IFNβ_1b治療;對照組在急性期採用MPPT治療,緩解期註射0.9%氯化鈉溶液。觀察兩組急性期療效、不同時期的複髮率、Kurtzke擴展殘疾狀況量錶(EDSS )評分、磁共振(MRI )腦部病竈數量和體積及IFNβ_1b的不良反應。結果急性期MPPT治療的84例患者,總有效率達97.62%。觀察組兩年總複髮率(31.71%)低于對照組(71.43%),差異有統計學意義( P<0.01);觀察組第2年複髮率低于對照組,差異有統計學意義( P<0.01);且觀察組第2年複髮率低于第1年,差異有統計學意義( P<0.05)。第2年末-初始EDSS評分,觀察組明顯低于對照組,差異有統計學意義( P<0.01)。0~12箇月和0~24箇月,觀察組MRI頭部病竈數量和體積均明顯低于對照組,差異有統計學意義( P<0.05)。結論對于RRMS患者,採用急性期MPPT結閤緩解期IFN_β治療可取得較好的療效。
목적:관찰급성기갑발니룡결합완해기IFN_β치료복발완해형다발성경화증(RRMS )적료효。방법84례RRMS환자,수궤분위관찰조급대조조,매조각42례。관찰조재급성기채용갑발니룡충격요법(MPPT )치료,완해기채용IFNβ_1b치료;대조조재급성기채용MPPT치료,완해기주사0.9%록화납용액。관찰량조급성기료효、불동시기적복발솔、Kurtzke확전잔질상황량표(EDSS )평분、자공진(MRI )뇌부병조수량화체적급IFNβ_1b적불량반응。결과급성기MPPT치료적84례환자,총유효솔체97.62%。관찰조량년총복발솔(31.71%)저우대조조(71.43%),차이유통계학의의( P<0.01);관찰조제2년복발솔저우대조조,차이유통계학의의( P<0.01);차관찰조제2년복발솔저우제1년,차이유통계학의의( P<0.05)。제2년말-초시EDSS평분,관찰조명현저우대조조,차이유통계학의의( P<0.01)。0~12개월화0~24개월,관찰조MRI두부병조수량화체적균명현저우대조조,차이유통계학의의( P<0.05)。결론대우RRMS환자,채용급성기MPPT결합완해기IFN_β치료가취득교호적료효。
Objective To observe curative effect of treatment of methylprednisolone in acute phase combined with IFN_βin remission period on relapsing remitting multiple sclerosis.Methods 84 patients with Relapsing Remitting Multiple Sclerosis (RRMS ) were di-vided into observation group and control group randomly ,each group had 42 patients.Observation group was treated with methylpred-nisolone pulse therapy (MPPT) in the acute phase ,and with IFN beta_1b treatment in remission phase.Patients in control group were treated with MPPT in acute phase ,with injection of sodium chloride solution in remission period.The curative effect of two groups in acute stage ,recurrencing rates of different stages ,Kurtzke Expanded Disability Status Scale (EDSS ) ,nuclear magnetic resonance (MRI) number ,volume of brain lesions ,and adverse reaction of IFNβ_1b were observed.Results Among 84 cases in the acute phase with MPPT treatment ,the total effective rate was 87.62% ;total recurrence rate of two years of the observation group (31.71% ) was lower than that of the control group (71.43% ) ,the difference was statistically significant ( P<0.01).The second_year recurrence rate of the observation group was lower than control group ,the difference was statistically significant ( P<0.05 ).The second_year recurrence rate of the test group is lower than the first year ,the difference was statistically significant ( P<0.05).At the end of sec-ond year ,subtractting the initial EDSS value ,the observation group was lower than that of the control group ,the difference was statis-tically significant ( P<0.01).0~12 and 0~24 months ,number and volume of brain lesions of MRI in observation group were lower than control group ,the difference was statistically significant ( P<0.05). Conclusions For RRMS patients ,the treatment of the MPPT in acute phase combined with IFN_βin remission period may have a better effect.